Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis
Abstract Background: New psychoactive substances (NPS) have been increasingly consumed by people who use drugs in recent years, which pose…
Abstract Background: New psychoactive substances (NPS) have been increasingly consumed by people who use drugs in recent years, which pose…
Abstract Alzheimer’s disease (AD) is a debilitating neurodegenerative disease that is affecting an increasing number of people. It is characterized…
Abstract As a consequence of an increasingly aging population, the number of people affected by neurodegenerative disorders, such as Alzheimer’s…
Abstract Medical marijuana is increasingly prescribed as an analgesic for a growing number of indications, amongst which terminal cancer and…
Abstract Background: Around 30% of the population will experience herpes zoster (HZ), 10% of whom develop postherpetic neuralgia (PHN). Together,…
Abstract The identification and cloning of the two major cannabinoid (CB1 and CB2) receptors together with the discovery of their…
Abstract The cannabinoid CB2 receptor (CB2R) represents a promising therapeutic target for various forms of tissue injury and inflammatory diseases.…
Abstract Therapeutic strategies in dystonia have evolved considerably in the past few decades. Three major treatment modalities include oral medications,…
Abstract Cannabidiol (CBD) has been established to have both acute and long-lasting effects to reduce fear memory expression. The long-lasting…
Abstract Background: Child health is a key priority on the global health agenda, yet the provision of essential and emergency…